The global omega-3 market was valued at USD 2.62 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 7.9% from 2024 to 2030. This anticipated growth is primarily due to the increasing incorporation of omega-3 ingredients into the human diet to support brain and heart health. Additionally, the rising consumer investment in healthcare and overall well-being is expected to further boost product demand. The market is currently experiencing continuous diversification in its product offerings as consumers seek alternatives to traditional fish oil. Among these alternatives, krill oil has emerged as one of the most popular sources of omega-3 fatty acids due to its superior properties compared to conventional fish oil.

In regions like Europe and North America, a significant number of consumers prefer krill oil over other fish oil sources, largely due to its lower incidence of acid reflux, more pleasant taste, and smaller pill sizes. These consumer preferences are anticipated to drive demand for krill oil during the forecast period.

In the United States, the demand for omega-3 fatty acids is projected to grow significantly over the next few years, fueled by increasing consumer awareness regarding the various health benefits associated with omega-3, including its ability to lower blood pressure, reduce cholesterol levels, and mitigate risks related to heart diseases. Furthermore, a growing preference among consumers for a healthy and nutritious diet is expected to enhance product demand in the near future.

Numerous manufacturers operating in the U.S., including BioProcess Algae, Martek Biosciences Corporation, and Omega Protein Corporation, are intensifying their focus on research and development activities to introduce pharmaceutical-grade omega-3 products into the market. The increasing consumption of enhanced medicines aimed at treating and preventing chronic diseases is likely to spur overall omega-3 consumption in the coming years, further solidifying the market's growth trajectory.

Gather more insights about the market drivers, restrains and growth of the Omega 3 Market

Type Insights

Docosahexaenoic acid (DHA) dominated the omega-3 market in 2023, capturing a revenue share of more than 56%.

• This significant share can be attributed to the increasing utilization of DHA in infant formulas aimed at improving overall infant health.
• As the most essential and abundant omega-3 fatty acid in the human diet, DHA plays a vital role in maintaining overall health and well-being.

Importance of DHA in Development:

• DHA is crucial for the development and maturation of an infant's brain and eyesight, making it a key ingredient in infant nutrition.
• Beyond its role in infant health, DHA is widely incorporated into nutritional supplements and fortified foods, enhancing their health benefits.
• It is also utilized in the treatment of various health conditions, including dementia, attention deficit hyperactivity disorder (ADHD), coronary artery disease (CAD), and Type 2 diabetes.
• The health advantages of DHA have led to its inclusion in geriatric nutrition products, emphasizing its significance for older adults.

Omega-3 Polyunsaturated Fatty Acids (PUFAs):

• Omega-3 PUFAs, including DPA (Docosapentaenoic acid), are associated with various cardiovascular health benefits.
• These fatty acids may help lower the risk of heart disease by reducing triglyceride levels, minimizing inflammation, improving blood vessel function, and decreasing the risk of arrhythmias.
• Additionally, omega-3 PUFAs are essential for brain health and development. While DHA is the most studied omega-3 PUFA in relation to brain function, there is increasing evidence supporting the unique benefits of DPA.
• DPA has been linked to neuroprotective properties and may offer potential benefits for neurodegenerative and neurological disorders.

Eicosapentaenoic acid (EPA) is expected to see increased global demand during the forecast period.

• This anticipated growth is driven by its numerous health benefits, which include preventing inflammation, managing high blood pressure, reducing the risk of coronary heart diseases, and lowering excessive triglyceride levels in the blood.
• EPA is also utilized in the treatment of diabetes, addressing side effects related to chemotherapy, and aiding recovery from surgeries, further enhancing its appeal in the market.

Order a free sample PDF of the Omega 3 Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com/

Follow Us: LinkedIn | Twitter